Related references
Note: Only part of the references are listed.Acute Myocardial Infarction and Atherosclerosis of the Coronary Arteries in Patients Treated with Drugs Against Osteoporosis: Calcium in the Vessels and not the Bones?
Peter Vestergaard
CALCIFIED TISSUE INTERNATIONAL (2012)
Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
Jacqueline R. Center et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Oral bisphosphonates are associated with reduced mortality after hip fracture
L. A. Beaupre et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study
P. N. Sambrook et al.
OSTEOPOROSIS INTERNATIONAL (2011)
The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank
Frederick Wolfe et al.
RHEUMATOLOGY (2011)
Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events
Lu Wang et al.
ANNALS OF INTERNAL MEDICINE (2010)
Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
Patrick Haentjens et al.
ANNALS OF INTERNAL MEDICINE (2010)
Potential Mediators of the Mortality Reduction With Zoledronic Acid After Hip Fracture
Cathleen S. Colon-Emeric et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Zoledronate in the Repair of Chronically Infarcted Rat Myocardium
Hyosook Hwang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis)
Sammy Elmariah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
Dana Bliuc et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis - A cohort and nested case-control analysis
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2008)
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case-control study
Zurab Nadareishvili et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Biologic treatment of rheumatoid arthritis and the risk of malignancy - Analyses from a large US observational study
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture
C. Colon-Emeric et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
D Hamerman
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Epidemiology of osteoporotic fractures
Olof Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Bone mineral density in patients with rheumatoid arthritis treated with infliximab
M Vis et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis - A population-based cohort study
H Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gamma delta T cells in response to aminobisphosphonates is inhibited by statins
RE Hewitt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Osteoporosis and cardiovascular disease - Brittle bones and boned arteries, is there a link?
SI McFarlane et al.
ENDOCRINE (2004)
A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture
SR Majumdar et al.
ANNALS OF INTERNAL MEDICINE (2004)
Osteoporosis prevalence and levels of treatment in primary care: The Australian BoneCare Study
J Eisman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Lymphoma in rheumatoid arthritis - The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
F Dieli et al.
BLOOD (2003)
Predicting mortality in patients with rheumatoid arthritis
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2003)
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
DH Solomon et al.
CIRCULATION (2003)
Assessment of mortality in patients enrolled in a risedronate clinical trial program: A retrospective cohort study
M Steinbuch et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2002)
Recent advances in 99mTc radio pharmaceuticals
Y Arano
ANNALS OF NUCLEAR MEDICINE (2002)
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
TM Huusko et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Bisphosphonate therapy and vascular calcification
MR Goldstein
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Risk of mortality following clinical fractures
JA Cauley et al.
OSTEOPOROSIS INTERNATIONAL (2000)